search
Back to results

A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease

Primary Purpose

Asymmetric Parkinson's Disease

Status
Unknown status
Phase
Not Applicable
Locations
Israel
Study Type
Interventional
Intervention
repetitive transcranial stimulation (r-TMS)
repetitive transcranial stimulation (r-TMS)
Sponsored by
Sheba Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asymmetric Parkinson's Disease focused on measuring UPDRS

Eligibility Criteria

40 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • PD patients with asymmetric disease aged 40 years or older, diagnosed as idiopathic PD according to the UK Brain Bank criteria, with Hoehn & Yahr stages II - IV while "off".
  • Participants on antidepressants should be at least 2 months on stable therapy.

Exclusion Criteria:

  1. Patients who have concomitant epilepsy, a history of seizure or heat convulsion or history of epilepsy in first degree relative.
  2. Patients on neuroleptics.
  3. Patients with unstable medical disorder.
  4. History or current unstable hypertension.
  5. History of head injury or neurosurgical interventions.
  6. History of any metal in the head (outside the mouth).
  7. Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps.
  8. History of migraine or frequent or severe headaches.
  9. Current hearing loss.
  10. The presence of cochlear implants
  11. Current drug abuse or alcoholism.
  12. Pregnancy or not using a reliable method of birth control.
  13. Participation in current clinical study or clinical study within 30 days prior to this study.

Sites / Locations

  • Sheba Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Active repetitive Transcranial Stimulation

Sham Stimulation

Arm Description

Each patient will be given 12 stimulation sessions, over a period of 4 weeks, and then a maintenance phase consisting of 8 stimulation sessions for the first 4 weeks and additional 4 stimulation sessions during the following 4 weeks.

The control arm group will receive sham stimulations in identical treatment and maintenance schedules.

Outcomes

Primary Outcome Measures

Decrease in Unified Parkinson's Disease Rating Scale (UPDRS) score
A decrease in the total UPDRS score in general and in the Motor UPDRS (part 3) score.

Secondary Outcome Measures

CGIS
Rater and patient's opinion on the change in thier PD due to the TMS treatment
Decrease in time in Pegboard test
Increase in Tapping test
Decrease in Time Up&Go test
Patient has to get up from a chair, walk 3 meters, turn around and return to sit on the chair.
Increase in Word fluency
Number of words the patient can think of that start with a certian letter or belong to a certian catagory, in one minute.
Increase in Digits Forward & Backwards test
Number of Participants with Adverse Events as a Measure of Safety and Tolerability

Full Information

First Posted
May 30, 2011
Last Updated
September 10, 2014
Sponsor
Sheba Medical Center
Collaborators
Brainsway
search

1. Study Identification

Unique Protocol Identification Number
NCT01367782
Brief Title
A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease
Official Title
A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
September 2014
Overall Recruitment Status
Unknown status
Study Start Date
May 2011 (undefined)
Primary Completion Date
December 2014 (Anticipated)
Study Completion Date
December 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sheba Medical Center
Collaborators
Brainsway

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to test the effects of low frequency deep rTMS using the novel H-coil on the motor, affective and cognitive deficits in patients with asymmetric Parkinson's disease (PD), to establish its safety in this population and to test effects of maintenance treatments.
Detailed Description
PD patients with asymmetric disease aged 40 years or older, diagnosed as idiopathic PD according to the UK Brain Bank criteria, with Hoehn & Yahr stages II - IV while "off" will be recruited. Participants on antidepressants should be at least 2 months on stable therapy. Patient will be excluded if: Patients who have concomitant epilepsy, a history of seizure or heat convulsion or history of epilepsy in first degree relative. Patients on neuroleptics. Patients with unstable medical disorder. History or current unstable hypertension. History of head injury or neurosurgical interventions. History of any metal in the head (outside the mouth). Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps. History of migraine or frequent or severe headaches. Current hearing loss. The presence of cochlear implants Current drug abuse or alcoholism. Pregnancy or not using a reliable method of birth control. Participation in current clinical study or clinical study within 30 days prior to this study. Patients will be to randomized to an active rTMS arm or to a sham stimulation arm. Each patient will be given 12 stimulation sessions, over a period of 4 weeks, and then a maintenance phase consisting of 8 stimulation sessions for the first 4 weeks and additional 4 stimulation sessions during the following 4 weeks. Active treatment with the H-coil will include stimulation over the motor cortex (1 Hz stimulation 110% of the motor threshold for 15 minutes) and over the prefrontal cortex (10Hz stimulation 100% of the motor threshold, 2 seconds each train, 20 seconds between trains, for 15 minutes). The control arm group will receive sham stimulations in identical treatment and maintenance schedules. Patients from the sham group who will complete the study will be given the opportunity to receive 12 sessions of real r-TMS treatment over 4 weeks as the treatment group. The following outcome measures will be taken prior to the treatment (screening visit), and at day 1, 10, 30, 60 and 90. Evaluation will be while subjects are both at "on" and "off". Motor: Unified Parkinson's Disease Rating Scale (UPDRS ) Clinical Global Impression of Severity (CGIS) Pegboard test. Tapping test Up & Go test Abnormal Involuntary Movement Scale (AIMS) Mood and affect 1. Beck Depression Inventory (BDI) Cognition Mini mental State examination (MMSE) Digit forward and backward tests. Word fluency. Frontal Assessment Battery (FAB) Side effects will be closely monitored by the researchers and will be promptly reported to the IRB.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asymmetric Parkinson's Disease
Keywords
UPDRS

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
51 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Active repetitive Transcranial Stimulation
Arm Type
Active Comparator
Arm Description
Each patient will be given 12 stimulation sessions, over a period of 4 weeks, and then a maintenance phase consisting of 8 stimulation sessions for the first 4 weeks and additional 4 stimulation sessions during the following 4 weeks.
Arm Title
Sham Stimulation
Arm Type
Sham Comparator
Arm Description
The control arm group will receive sham stimulations in identical treatment and maintenance schedules.
Intervention Type
Device
Intervention Name(s)
repetitive transcranial stimulation (r-TMS)
Intervention Description
Active treatment with the H-coil will include stimulation over the motor cortex (1 Hz stimulation 110% of the motor threshold for 15 minutes) and over the prefrontal cortex (10Hz stimulation 100% of the motor threshold, 2 seconds each train, 20 seconds between trains, for 15 minutes).
Intervention Type
Device
Intervention Name(s)
repetitive transcranial stimulation (r-TMS)
Intervention Description
Sham treatment with the H-coil will include sham stimulation over the motor cortex and over the prefrontal cortex.
Primary Outcome Measure Information:
Title
Decrease in Unified Parkinson's Disease Rating Scale (UPDRS) score
Description
A decrease in the total UPDRS score in general and in the Motor UPDRS (part 3) score.
Time Frame
3 months
Secondary Outcome Measure Information:
Title
CGIS
Description
Rater and patient's opinion on the change in thier PD due to the TMS treatment
Time Frame
3 months
Title
Decrease in time in Pegboard test
Time Frame
3 months
Title
Increase in Tapping test
Time Frame
3 months
Title
Decrease in Time Up&Go test
Description
Patient has to get up from a chair, walk 3 meters, turn around and return to sit on the chair.
Time Frame
3 months
Title
Increase in Word fluency
Description
Number of words the patient can think of that start with a certian letter or belong to a certian catagory, in one minute.
Time Frame
3 months
Title
Increase in Digits Forward & Backwards test
Time Frame
3 months
Title
Number of Participants with Adverse Events as a Measure of Safety and Tolerability
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: PD patients with asymmetric disease aged 40 years or older, diagnosed as idiopathic PD according to the UK Brain Bank criteria, with Hoehn & Yahr stages II - IV while "off". Participants on antidepressants should be at least 2 months on stable therapy. Exclusion Criteria: Patients who have concomitant epilepsy, a history of seizure or heat convulsion or history of epilepsy in first degree relative. Patients on neuroleptics. Patients with unstable medical disorder. History or current unstable hypertension. History of head injury or neurosurgical interventions. History of any metal in the head (outside the mouth). Known history of any metallic particles in the eye, implanted cardiac pacemaker, implanted neurostimulators, surgical clips (above the shoulder line) or any medical pumps. History of migraine or frequent or severe headaches. Current hearing loss. The presence of cochlear implants Current drug abuse or alcoholism. Pregnancy or not using a reliable method of birth control. Participation in current clinical study or clinical study within 30 days prior to this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Oren Cohen, MD
Phone
+972-3-5305296
Email
Oren.Cohen@sheba.health.gov.il
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oren Cohen, MD
Organizational Affiliation
Sheba Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Sheba Medical Center
City
Tel Hashomer
ZIP/Postal Code
52621
Country
Israel
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oren Cohen, MD
Email
Oren.Cohen@sheba.health.gov.il

12. IPD Sharing Statement

Learn more about this trial

A Double Blind Sham-controled Study to Evaluate the Influence of Low Frequency Repetitive Transcranial Stimulation (r-TMS) on Motor and Cognitive Measurements in Patients With Asymmetric Parkinson's Disease

We'll reach out to this number within 24 hrs